Loading organizations...
Madison Partners delivers comprehensive, fiduciary financial advisory services through a virtual model. The firm specializes in personal financial planning, including wealth management and retirement strategies. Leveraging modern technology, Madison Partners offers accessible, personalized guidance, integrating digital platforms with traditional financial wisdom to help clients navigate their financial landscapes and achieve objectives.
The firm was established with the insight that expert financial advice should be broadly accessible, combining innovative technological approaches with time-tested principles. This vision drove the creation of a service model designed to provide transparent, client-centric guidance, fostering more inclusive and digital engagement in wealth management.
Madison Partners primarily serves individuals and families seeking dedicated support in managing their wealth. The company’s vision is to empower clients by simplifying financial planning, making sophisticated wealth management strategies understandable and attainable. They aim to be a trusted partner, fostering long-term financial security and prosperity for their clients.
Madison Partners has 2 tracked investments across 1 company. The latest tracked deal is $50.0M Series B in OncoMyx Therapeutics in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2021 | OncoMyx Therapeutics | $50.0M Series B | B Capital Group, Benjamin Rovinski, Ph.d. | Boehringer Ingelheim, City Hill Ventures, Delos Capital, Korea Investment Partners, Lyzz Capital, Xeraya Capital |
| Jun 5, 2019 | OncoMyx Therapeutics | $25.0M Series A | Kanad DAS, TIM Xiao, Jason Rushton | City Hill Ventures, Korea Investment Partners |